Breathing treatment tested to fight COVID-19 lung damage
NCT ID NCT04469491
Summary
This study is testing whether inhaling a medication called interferon beta can help hospitalized COVID-19 patients who need oxygen. The goal is to see if this inhaled treatment can reduce how much oxygen support patients require over 15 days. The trial involves 74 adults with confirmed COVID-19 who are hospitalized and receiving oxygen therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Compiègne-Noyon
Compiègne, 60200, France
-
CH d'Abbeville
Abbeville, 80142, France
-
CH de Saint-Quentin
Saint-Quentin, 02100, France
-
CH de Tourcoing
Tourcoing, 59208, France
-
CH de l'Arrondissement de Montreuil-sur-mer
Rang-du-Fliers, 62180, France
-
CH de valenciennes
Valenciennes, 59322, France
-
CHU Amiens
Amiens, 80480, France
Conditions
Explore the condition pages connected to this study.